Starting on November 27, 2018
◊ Veranstalter: Novartis
Second webinar of the materiality assessment webinar series, which will focus on Novartis' impact valuation work
Novartis will share their current approach to quantifying and monetizing impact dimensions of their corporate responsibility material issue areas.
John Elkington, Chair of our Impact Valuation Advisory Committee, will join in and set the scene. He will embed their impact valuation work into the global context and explore what it will take to strengthen the momentum of monetizing impacts across material issue areas.
Moderation: Rob Cameron, Chief Executive, SustainAbility
Further information here
As an important stakeholder to Novartis, you are kindly invited to join in on the conversation.
In case of questions, please contact: firstname.lastname@example.org